​

United Therapeutics Ownership | Who Owns United Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

United Therapeutics Ownership Summary

United Therapeutics is owned by 96.94% institutional investors, 1.77% insiders, and 1.29% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.83% of UTHR shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.25% of its assets in United Therapeutics shares.

UTHR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockUnited Therapeutics96.94%1.77%1.29%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.33M11.83%$1.53B
Blackrock5.47M11.64%$1.74B
Vanguard group4.44M9.96%$1.57B
Wellington management group llp2.46M5.52%$869.36M
Avoro capital advisors2.37M5.25%$681.02M
State street2.29M4.88%$730.83M
Renaissance2.09M4.68%$737.22M
Fmr1.47M3.30%$519.17M
Geode capital management1.14M2.55%$401.18M
Aqr capital management975.44K2.19%$344.18M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management101.15K15.38%$29.06M
Avoro capital advisors2.37M11.93%$681.02M
Palo alto investors lp95.48K5.84%$27.44M
Summit street capital management32.44K4.07%$11.45M
Soleus capital management209.79K3.99%$60.28M
Poplar forest capital59.88K3.89%$21.13M
Nepsis47.77K3.82%$13.73M
Nitorum capital67.53K2.88%$19.40M
Deerfield management company, l.p. (series c)540.63K2.82%$155.35M
Logos global management lp85.00K2.70%$24.42M

Top Buyers

HolderShares% AssetsChange
Norges bank430.12K0.02%430.12K
Fmr1.47M0.03%393.78K
State street2.29M0.03%359.11K
Morgan stanley806.99K0.02%270.78K
Deerfield management company, l.p. (series c)540.63K2.82%265.40K

Top Sellers

HolderShares% AssetsChange
Citadel advisors---719.31K
Wellington management group llp2.46M0.16%-706.96K
Vaughan nelson investment management---328.78K
Avoro capital advisors2.37M11.93%-305.00K
Squarepoint ops---177.50K

New Positions

HolderShares% AssetsChangeValue
Norges bank430.12K0.02%430.12K$151.76M
Sofinnova investments118.51K2.08%118.51K$34.05M
Logos global management lp85.00K2.70%85.00K$24.42M
Readystate asset management lp25.40K0.26%25.40K$8.09M
Twinbeech capital lp23.28K0.15%23.28K$6.69M

Sold Out

HolderChange
Advisornet financial-1.00
Transamerica financial advisors-1.00
Financial gravity asset management-1.00
Rothschild investment-1.00
Financial synergies wealth advisors-1.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20256810.59%43,719,199-1.26%961.00%3584.99%214-4.89%
Mar 31, 2025670-2.33%43,709,344-0.77%971.00%338-9.38%2236.70%
Dec 31, 2024628-1.10%59,260,45237.20%1321.42%3408.63%191-15.49%
Sep 30, 20246267.56%43,411,015-5.14%971.03%3080.65%22315.54%
Jun 30, 20245736.90%45,745,1772.56%971.08%30010.70%1929.09%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Mid-Cap ETF1.47M3.25%-2.64K
Vanguard US Total Market Shares ETF1.41M3.14%1.06K
Vanguard Total Stock Mkt Idx Inv1.42M3.13%-29.92K
Vanguard Small Cap Index1.10M2.42%-7.03K
Vanguard Health Care Inv910.86K2.01%-
Vanguard Small Cap Value Index Inv704.76K1.56%1.50K
Vanguard Windsor Investor Shares488.35K1.09%-40.43K
Vanguard Institutional Extnd Mkt Idx Tr485.01K1.07%-209.76K
FullerThaler Behavioral Sm-Cp Eq R6462.63K1.03%-38.70K
FullerThaler Behavioral Small-Cap Equity462.63K1.03%-38.70K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 21, 2025MAHON PAUL A EVP & GENERAL COUNSELSell$718.64K
Aug 21, 2025MAHON PAUL A EVP & GENERAL COUNSELSell$182.74K
Aug 21, 2025MAHON PAUL A EVP & GENERAL COUNSELSell$91.84K
Aug 21, 2025MAHON PAUL A EVP & GENERAL COUNSELSell$442.94K
Aug 21, 2025MAHON PAUL A EVP & GENERAL COUNSELSell$1.31M

Insider Transactions Trends

DateBuySell
2025 Q3-20
2025 Q2-61
2025 Q1-145
2024 Q4-174
2024 Q3-314

UTHR Ownership FAQ

Who Owns United Therapeutics?

United Therapeutics shareholders are primarily institutional investors at 96.94%, followed by 1.77% insiders and 1.29% retail investors. The average institutional ownership in United Therapeutics's industry, Biotech Stocks , is 304.14%, which United Therapeutics falls below.

Who owns the most shares of United Therapeutics?

United Therapeutics’s largest shareholders are Blackrock funding, inc. /de (5.33M shares, 11.83%), Blackrock (5.47M shares, 11.64%), and Vanguard group (4.44M shares, 9.96%). Together, they hold 33.42% of United Therapeutics’s total shares outstanding.

Does Blackrock own United Therapeutics?

Yes, BlackRock owns 11.64% of United Therapeutics, totaling 5.47M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.74B$. In the last quarter, BlackRock decreased its holdings by -98.516K shares, a -1.77% change.

Who is United Therapeutics’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is United Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.38% of its assets in 101.15K United Therapeutics shares, valued at 29.06M$.

Who is the top mutual fund holder of United Therapeutics shares?

iShares Core S&P Mid-Cap ETF is the top mutual fund holder of United Therapeutics shares, with 3.25% of its total shares outstanding invested in 1.47M United Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools